FDA NDC Directory · JSON-LD · Markdown

ZYPREXA Intramuscular

NDC 0002-7597 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, FOR SOLUTION

Generic nameOlanzapine
Labeler / ManufacturerEli Lilly and Company
Marketing categoryNew Drug Application (innovator) · App NDA021253
Dosage form / routeINJECTION, POWDER, FOR SOLUTION · INTRAMUSCULAR
Active ingredientsOLANZAPINE (10 mg/2mL)
Marketing started20040401
Marketing ended20260630
Package count1

External sources

Source: openFDA. Public-domain (CC0).